Adsilico
Adsilico helps medical device teams establish safety and efficacy before human testing by creating simulation-ready virtual patients. The company builds computational models and runs in silico trials using generative AI to produce customizable, high-fidelity digital representations of anatomy, physiology, and pathology. Its platform scales virtual patient populations from dozens to thousands to accelerate R&D, optimize trial design, and reduce clinical risk. Adsilico operates as a B2B provider focused on medical device companies and partners with device developers to integrate simulations into preclinical and regulatory workflows. The technology targets reduced time-to-market and lower clinical failure rates for medical devices.
Adsilico
Adsilico helps medical device teams establish safety and efficacy before human testing by creating simulation-ready virtual patients. The company builds computational models and runs in silico trials using generative AI to produce customizable, high-fidelity digital representations of anatomy, physiology, and pathology. Its platform scales virtual patient populations from dozens to thousands to accelerate R&D, optimize trial design, and reduce clinical risk. Adsilico operates as a B2B provider focused on medical device companies and partners with device developers to integrate simulations into preclinical and regulatory workflows. The technology targets reduced time-to-market and lower clinical failure rates for medical devices.